Short answer: the Ozempic pill (Ozempic tablets, oral semaglutide) starts at 1.5 mg once a day for 30 days, goes up to 4 mg on days 31 to 60, and can go up to 9 mg from day 61 if more blood sugar control is needed. Rybelsus, the older semaglutide pill, follows the same 30-day steps with different numbers: 3 mg, then 7 mg, then 14 mg. You take either one in the morning on an empty stomach with up to 4 ounces of plain water, then wait at least 30 minutes before eating, drinking or taking other pills. If you miss a dose, skip it and take the next one the following day.
Every number below comes from the current FDA label for Rybelsus and Ozempic tablets on DailyMed (one shared label, revised January 2026). Section numbers are in brackets so you can check each one yourself. This is a plain summary of the label, not medical advice. Your prescriber decides your dose and when it changes.
What the Ozempic pill is
For years, "the Ozempic pill" was just a nickname for Rybelsus, because Ozempic itself was only a weekly injection. That changed. The FDA label now covers two semaglutide tablets made by Novo Nordisk: Rybelsus and Ozempic tablets. Both are taken once a day by mouth.
Both tablets are approved for adults with type 2 diabetes, alongside diet and exercise, to improve blood sugar control. They are also approved to lower the risk of major heart events (heart-related death, non-fatal heart attack or non-fatal stroke) in adults with type 2 diabetes who are at high risk for those events [Section 1].
The two pills use different strengths. Rybelsus comes in 3 mg, 7 mg and 14 mg tablets. Ozempic tablets come in 1.5 mg, 4 mg and 9 mg tablets [Section 3]. The label is clear that the two products are not substitutable on a mg-to-mg basis [Section 2.1]. A 4 mg Ozempic tablet is not a weaker version of a 7 mg Rybelsus tablet. They are different products with their own dose steps.
Ozempic tablets dosing chart
The label sets out a 30-day start, a 30-day step up, and then a maintenance dose [Section 2.2]:
- Days 1 to 30: 1.5 mg once a day. The label notes this starting dose is not effective for blood sugar control. Its job is to let your stomach get used to the drug.
- Days 31 to 60: 4 mg once a day.
- Day 61 or later: stay at 4 mg if no extra blood sugar control is needed, or go up to 9 mg once a day if it is.
The label gives the reason for the slow start: following the step-up schedule is meant to reduce the risk of stomach and gut side effects such as nausea [Section 2.2].
Rybelsus dosing chart
Rybelsus uses the same timeline with its own numbers [Section 2.2]:
- Days 1 to 30: 3 mg once a day. Like the Ozempic tablet starting dose, the label says this dose is not effective for blood sugar control.
- Days 31 to 60: 7 mg once a day.
- Day 61 or later: stay at 7 mg if no extra blood sugar control is needed, or go up to 14 mg once a day if it is.
So the highest daily dose in the label is 9 mg for Ozempic tablets and 14 mg for Rybelsus. The label also says not to take more than one tablet per day [Section 2.1]. If your prescriber wants a higher dose, that means a higher-strength tablet, not two tablets.
If you want a deeper look at Rybelsus alone, Dose Track has a Rybelsus dosing chart with every step.
Switching between Rybelsus and Ozempic tablets
Because the two pills use different numbers, the label includes a switch table [Section 2.3]:
- Rybelsus 7 mg matches Ozempic tablets 4 mg.
- Rybelsus 14 mg matches Ozempic tablets 9 mg.
Two rules come with it. First, do not switch during the first 30 days (the starting phase). Second, when you switch, start the new tablet the day after you stop the old one [Section 2.3].
Switching from Ozempic shots to the pill
The label also covers moving from the weekly Ozempic injection to a tablet [Section 2.4]. Only people on the 0.5 mg injection dose are covered by this switch. One week after the last 0.5 mg shot, the label says to start either 7 mg or 14 mg of Rybelsus, or 4 mg or 9 mg of Ozempic tablets, once a day. Which one is your prescriber's call.
How to take the pill
How you take the tablet matters as much as the dose. The label's instructions are specific [Section 2.1]:
- Morning, empty stomach. Take one tablet once a day in the morning before anything else.
- Water only, up to 4 ounces. That is about half a cup. Do not take it with coffee, juice, tea or any other liquid.
- Swallow it whole. Do not split, crush, chew or dissolve the tablet.
- Wait at least 30 minutes. After you swallow it, wait at least 30 minutes before you eat, drink anything, or take any other pills by mouth.
The label links these rules to how the drug is absorbed [Section 2.1, pointing to Section 12.3]. In plain terms, food, extra liquid and other pills in your stomach can get in the way of how much semaglutide your body takes in. That is why the morning routine is strict. A simple way to build the habit: keep the bottle next to a small glass by your bed, take the tablet when you wake up, and start a 30-minute timer before breakfast or your morning coffee.
If you take other morning pills, ask your prescriber or pharmacist how to fit them around the 30-minute wait. Do not guess.
What to do if you miss a dose
The label's rule is short: if a dose is missed, skip it and take the next dose the following day [Section 2.1]. Do not take two tablets the next day to catch up, since the label limits you to one tablet per day.
This is different from the weekly Ozempic shot, which has its own missed-dose window. If you have used the injection before, do not carry its rules over to the pill. The pill is daily, so a missed day is simply skipped.
Is the Wegovy pill the same thing?
No. Wegovy tablets are also oral semaglutide, but they sit on a separate label with a different use and a different dose range. The Wegovy label starts tablets at 1.5 mg once a day for 30 days, steps up every 30 days, and lists 25 mg once a day as the maintenance dose for weight reduction and heart risk reduction in adults [Wegovy label, Sections 2.2 and 2.3]. Do not use the Ozempic or Rybelsus chart for Wegovy tablets, or the other way around. For more on how the brands differ, see Ozempic vs Wegovy dose differences from the labels.
Quick reference
- Ozempic tablets: 1.5 mg (days 1 to 30), 4 mg (days 31 to 60), then 4 mg or 9 mg [Section 2.2].
- Rybelsus: 3 mg (days 1 to 30), 7 mg (days 31 to 60), then 7 mg or 14 mg [Section 2.2].
- Not interchangeable mg for mg. Rybelsus 7 mg = Ozempic tablets 4 mg; Rybelsus 14 mg = Ozempic tablets 9 mg [Sections 2.1 and 2.3].
- How to take: morning, empty stomach, up to 4 ounces of plain water, swallow whole, wait at least 30 minutes [Section 2.1].
- Missed dose: skip it, take the next one the following day; never more than one tablet a day [Section 2.1].
A short note on tracking your doses
A daily pill with a 30-day step-up is easy to lose track of. Around day 28 it is common to wonder whether you already moved up, which strength is in the bottle, or whether today's tablet was taken before the coffee. A simple log answers those questions in seconds and gives your prescriber real dates at your next visit.
At minimum, write down the date and time you took each tablet, the strength, when you started each step, any missed days, and any side effects such as nausea. A notebook works. So does an app. Dose Track lets you set a daily reminder, log each tablet in a tap, and keep the step-up dates in one place next to any other medications you take. If you also use injections, it can hold both. You can see how it works on the Dose Track GLP-1 tracker page.
Whatever you use, the log is there to help you follow the plan your prescriber set, not to change it. If something feels off, such as side effects that will not settle or doses you keep missing, bring your notes to your prescriber and let them decide the next step.
Sources
- RYBELSUS and OZEMPIC (semaglutide) tablets, prescribing information, Novo Nordisk, revised 1/2026. DailyMed set ID 27f15fac-7d98-4114-a2ec-92494a91da98: dailymed.nlm.nih.gov. Sections 1, 2.1, 2.2, 2.3, 2.4 and 3.
- WEGOVY (semaglutide) injection and tablets, prescribing information, Novo Nordisk. DailyMed set ID ee06186f-2aa3-4990-a760-757579d8f77b: dailymed.nlm.nih.gov. Sections 2.2 and 2.3.

